secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001193125-25-158442
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet to acquire Monogram Technologies for ~$177M upfront plus CVR up to $12.37/share
--------------------------------------------------------------------------------

- Equity value ~$177M ($4.04/share cash upfront); enterprise value ~$168M.
- Common stockholders receive non-tradeable CVR up to $12.37/share if product, regulatory and revenue milestones through 2030 are met.
- Acquisition neutral to adjusted EPS in 2025-2027, accretive in 2028+; expected to contribute to revenue growth beginning 2027.
- Monogram's semi-autonomous TKA robot (FDA 510(k) March 2025) and fully autonomous system in development will expand Zimmer Biomet's ROSA robotics platform.
- Closing expected later this year, subject to Monogram stockholder approval, regulatory clearances and other customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525158442/0001193125-25-158442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525158442/d76564d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-158442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer